The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 - PubMed (original) (raw)
. 1995 Nov 30;378(6556):457-62.
doi: 10.1038/378457a0.
Affiliations
- PMID: 7477400
- DOI: 10.1038/378457a0
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3
P Ghosh et al. Nature. 1995.
Abstract
A complex between HLA-DR3 and a fragment of invariant chain called CLIP was isolated from a human cell line defective in antigen presentation and its X-ray crystal structure determined. Previous data indicate that this complex is an intermediate in class II histocompatibility maturation, occurring between invariant chain-DR3 and antigenic peptide-DR3 complexes. The structure shows that the CLIP fragment binds to DR3 in a way almost identical to that in which antigenic peptides bind class II histocompatibility glycoproteins. The structure is the substrate for the loading of antigenic peptides by an exchange process catalysed by DM.
Similar articles
- Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
Yaneva R, Springer S, Zacharias M. Yaneva R, et al. Biopolymers. 2009 Jan;91(1):14-27. doi: 10.1002/bip.21078. Biopolymers. 2009. PMID: 18767126 - Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.
Verreck FA, Fargeas CA, Hämmerling GJ. Verreck FA, et al. Eur J Immunol. 2001 Apr;31(4):1029-36. doi: 10.1002/1521-4141(200104)31:4<1029::aid-immu1029>3.0.co;2-q. Eur J Immunol. 2001. PMID: 11298327 - Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB, Arndt SO, Hämmerling GJ, Kropshofer H. Vogt AB, et al. Semin Immunol. 1999 Dec;11(6):391-403. doi: 10.1006/smim.1999.0197. Semin Immunol. 1999. PMID: 10625593 Review. - Another twist to MHC-peptide recognition.
Wilson IA. Wilson IA. Science. 1996 May 17;272(5264):973-4. doi: 10.1126/science.272.5264.973. Science. 1996. PMID: 8638141 Review. No abstract available.
Cited by
- Peculiarities of the Presentation of the Encephalitogenic MBP Peptide by HLA-DR Complexes Providing Protection and Predisposition to Multiple Sclerosis.
Mamedov AE, Filimonova IN, Smirnov IV, Belogurov AA. Mamedov AE, et al. Acta Naturae. 2021 Jan-Mar;13(1):127-133. doi: 10.32607/actanaturae.11008. Acta Naturae. 2021. PMID: 33959392 Free PMC article. - Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.
Amicosante M, Berretta F, Rossman M, Butler RH, Rogliani P, van den Berg-Loonen E, Saltini C. Amicosante M, et al. Respir Res. 2005 Aug 14;6(1):94. doi: 10.1186/1465-9921-6-94. Respir Res. 2005. PMID: 16098233 Free PMC article. Clinical Trial. - Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.
Dijkstra JM, Yamaguchi T. Dijkstra JM, et al. Immunogenetics. 2019 Mar;71(3):233-249. doi: 10.1007/s00251-018-1090-2. Epub 2018 Oct 30. Immunogenetics. 2019. PMID: 30377750 Review. - Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP, Bryant RA, Riese R, Verhelst S, Driessen C, Li Z, Bromme D, Ploegh HL, Chapman HA. Shi GP, et al. J Exp Med. 2000 Apr 3;191(7):1177-86. doi: 10.1084/jem.191.7.1177. J Exp Med. 2000. PMID: 10748235 Free PMC article. - Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis.
Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, Tomer Y. Menconi F, et al. Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16899-903. doi: 10.1073/pnas.1009511107. Epub 2010 Sep 13. Proc Natl Acad Sci U S A. 2010. PMID: 20837527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials